第 1 到 10 筆結果,共 10 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era | WEI-LI MA ; RUEY-LONG HONG ; PEI-JEN LOU ; MING YAO ; SHANG-JU WU ; CHUNG-WU LIN ; CHUN-WEI WANG ; Chang, Chin-Hao; ANN-LII CHENG ; SUNG-HSIN KUO | Cancer medicine | 0 | 0 | |
2 | 2022 | A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma | WEI-WU CHEN ; CHIA-LANG HSU ; RUEY-LONG HONG ; JEN-CHIEH LEE ; Chang, Koping; CHIH-WEI YU ; Chen, San-Chi; JHE-CYUAN GUO ; Chen, Mei-Lu; Hsu, Meng-Chi; Kung, Ting-Fang; ANN-LII CHENG ; Yen, Chueh-Chuan | Clinical cancer research : an official journal of the American Association for Cancer Research | 6 | 6 | |
3 | 2017 | Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma | WEN-CHI YANG ; CHUN-WEI WANG ; RUEY-LONG HONG ; CHIAO-LING TSAI ; MING YAO ; JIH-LUH TANG ; CHUNG-WU LIN ; ANN-LII CHENG ; SUNG-HSIN KUO | Journal of Radiation Research | 9 | 9 | |
4 | 2012 | Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy | ZHONG-ZHE LIN ; CHIUN HSU ; Hu F.-C.; YU-YUN SHAO ; DWANG-YING CHANG ; CHIH-HSIN YANG ; RUEY-LONG HONG ; CHIH-HUNG HSU ; ANN-LII CHENG | Oncologist | 8 | 10 | |
5 | 2006 | Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis | CHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; RUEY-LONG HONG ; Chang C.-J.; ANN-LII CHENG | Cancer Epidemiology Biomarkers and Prevention | 67 | 51 | |
6 | 2002 | Prognostic value of multidrug resistance 1, glutathione-S-transferase-π and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy | CHIH-HUNG HSU ; Chen C.-L.; RUEY-LONG HONG ; Chen K.-L.; Lin J.-F.; ANN-LII CHENG | Oncology | 31 | 25 | |
7 | 1997 | MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer | CHIUN HSU ; KUN-HUEI YEH ; RUEY-LONG HONG ; CHIH-HSIN YANG ; Lin M.-T.; YAO-CHANG CHEN ; ANN-LII CHENG | Journal of the Formosan Medical Association | 4 | 3 | |
8 | 1997 | A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers | KUN-HUEI YEH ; ANN-LII CHENG ; Lin M.-T.; RUEY-LONG HONG ; CHIH-HUNG HSU ; Lin J.-F.; KING-JEN CHANG ; PO-HUANG LEE ; YAO-CHANG CHEN | Anticancer Research | 32 | 27 | |
9 | 1995 | Clinicopathologic characteristics of helicobacter pyloric seropositive gastric adenocarcinomas | Lee W.-J.; Lin J.-T.; WEN-CHUNG LEE ; CHIA-TUNG SHUN ; RUEY-LONG HONG ; ANN-LII CHENG ; PO-HUANG LEE ; Wei T.-C.; Chen K.-M. | Journal of Clinical Gastroenterology | 13 | 13 | |
10 | 1994 | Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study | ANN-LII CHENG ; Su I.-J.; Chen C.-C.; HWEI-FANG TIEN ; Lay J.-D.; Chen B.-R.; YEONG-SHIAU PU ; RUEY-LONG HONG ; MING-CHING SHEN ; Wang C.-H.; YAO-CHANG CHEN | Journal of Clinical Oncology | 50 | 46 |